SCHEMBL23716355

SCHEMBL23716355

Bc1ccc(Cc2ccc(Cl)c(Cl)c2)nc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PNMT P11086 2/20 0.42
IDO1 P14902 3/20 0.40
SLC6A2 P23975 2/20 0.40
SLC6A4 P31645 2/20 0.40
SLC6A3 Q01959 2/20 0.40
ALDH1A1 P00352 2/20 0.40
HTT P42858 2/20 0.40
POLB P06746 1/20 0.40
TAAR1 Q96RJ0 1/20 0.38
ADORA2A P29274 1/20 0.37
NPC1 O15118 2/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C19 P33261 1/20 0.36
TSHR P16473 2/20 0.36
MAPK1 P28482 2/20 0.36
KMT2A Q03164 1/20 0.36
HSD17B10 Q99714 1/20 0.36
TDP1 Q9NUW8 1/20 0.35
RNASEH1 O60930 1/20 0.35
GBA1 P04062 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23716095 0.87 GPR52 (0.34) MAPK1
SCHEMBL17663857 0.83 IDO1 (0.42) PNMTIDO1SLC6A2SLC6A4SLC6A3
SCHEMBL23716077 0.81 HSP90AB1 (0.42) IDO1SLC6A2SLC6A4SLC6A3ALDH1A1
SCHEMBL17664391 0.80 PNMT (0.42) PNMTIDO1SLC6A2SLC6A4SLC6A3
SCHEMBL17664101 0.80 GBA1 (0.53) PNMTIDO1SLC6A2SLC6A4SLC6A3
SCHEMBL17664076 0.76 IDO1 (0.42) PNMTIDO1SLC6A2SLC6A4SLC6A3
SCHEMBL3129580 0.72 SLC6A2 (0.44) IDO1SLC6A2SLC6A4SLC6A3ALDH1A1
SCHEMBL17664001 0.72 GPR52 (0.35) IDO1SLC6A4MAPK1
SCHEMBL3298586 0.71 IDO1 (0.64) PNMTIDO1SLC6A2SLC6A4SLC6A3
SCHEMBL21383993 0.70 ALDH1A1 (0.59) PNMTIDO1SLC6A2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3209732-B1 SPHINGOSINE-1-PHOSPATE RECEPTOR MODULATORS FOR TREATMENT OF CARDIOPULMONARY DISORDERS SCRIPPS RESEARCH INST (US) 2021-08-04 EP disclosed